Semaglutide and Tirzepatide, (generic names) are now available as glucose lowering therapy for those who suffer from type II diabetes or chronic overweight with difficulty managing through diet and exercise alone. Both medications are administered as weekly injections to control your blood sugar levels by increasing insulin production, lowering the amount of sugar your liver makes and slowing down the rate at which food passes through your body, helping you to feel fuller for a longer period of time. Both require a calorie deficit diet and cardio with muscle-toning exercise.

The brand studies for Ozempic and Wegovy, (Semaglutide), revealed 14.9% reduction in body weight within 16 months, and brand, Mounjari, (Tirzepatide), a 22.5% reduction in body weight. However, it is important to understand that everyone is different and may experience different side effects or none at all. Side effects may include nausea, diarrhea, constipation or vomiting. We have found, through our extensive weight-loss programs, that if a person is not tolerating Semaglutide comfortably, they are able to tolerate Tirzepatide as a very effective alternative.

If you are taking Semaglutide and do not feel it is as effective as originally expected, it’s important to contact us right away because there are alternatives.